As expected, in BRCA-associated cancers, patients with BRCA1/2 biallelic alterations had significantly higher HRD scores than those with monoallelic alterations (P<0.01) and HRR wild-type patients (P<0.001). The gene discussed is BRCA1; the disease is cancer.